Individualize treatment when prescribing medical cannabis to older patients as efficacy data remains limited
- 11 Downloads
There is a growing interest in the use of cannabis for medical purposes, especially in older patients who experience pain, sleep difficulties, mood disturbances or neurological disorders that are poorly managed by current treatment options. However, efficacy data on the use of medical cannabis remains limited, yet the risk of known and potential adverse events are considerably high. Treatment should be individualized based on the characteristics of the patient and be closely monitored.
Compliance with ethical standards
Conflict of interest
The article was adapted from Drugs & Aging 2019;36(1):39–51  by employees of Adis International Ltd./Springer Nature, who are responsible for the article content and declare no conflicts of interest.
The preparation of this review was not supported by any external funding.
- 4.Johnson JR, Burnell-Nugent M, Lossignol D, et al. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167–79.CrossRefPubMedGoogle Scholar
- 11.Mucke M, Phillips T, Radbruch L, et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018;3:CD012182.Google Scholar
- 23.Beirness DJ, Beasley EE, P. B. A comparison of drug use by fatally injured drivers and drivers at risk. In: 20th International Council on Alcohol, Drugs, and Traffic Safety Conference; 2013.Google Scholar